Netherlands Institute for Innovative Ocular Surgery, Rotterdam, Netherlands.
Amnitrans Eyebank Rotterdam, Rotterdam, Netherlands.
BMJ Open Ophthalmol. 2022 Nov;7(Suppl 2):A7-A8. doi: 10.1136/bmjophth-2022-EEBA.17.
To evaluate the effect of graft preparation and organ-culture storage on endothelial cell density (ECD) and viability of Descemet membrane endothelial keratoplasty (DMEK) grafts.
DMEK grafts (n=27) were prepared at Amnitrans EyeBank Rotterdam from 27 corneas (15 donors) that were eligible for transplantation but could not be allocated due to the COVID-19-related cancellation of elective surgeries. Cell viability (by Calcein-AM staining) and ECD of 5 grafts originally scheduled for transplantation, were evaluated on the originally planned surgery day, whereas 22 grafts from paired donor corneas were evaluated either directly post-preparation or after 3-7 days of storage. ECD was analyzed by light microscopy (LM ECD) and Calcein-AM staining (Calcein-ECD) RESULTS: Light microscopy (LM) evaluation of all grafts showed an unremarkable endothelial cell monolayer directly after preparation. However, median Calcein-ECD for the 5 grafts initially allocated for transplantation was 18% (range 9-73%) lower than median LM ECD. For the paired DMEK grafts, Calcein-ECD determined by Calcein-AM staining on the day of graft preparation and after 3-7 days of graft storage showed a median decrease of 1% and 2%, respectively. Median percentage of central graft area populated by viable cells after preparation and after 3-7 days of graft storage was 88% and 92%, respectively.
Cell viability of most of the grafts will not be affected by preparation and storage. Endothelial cell damage may be observed for some grafts within hours after preparation with insignificant additional ECD changes during 3-7 days of graft storage. Implementing an additional post-preparation step in the eye bank to evaluate cell density before graft release for transplantation may help to reduce postoperative DMEK complications.
评估移植物制备和器官培养储存对Descemet 膜内皮角膜移植(DMEK)移植物内皮细胞密度(ECD)和活力的影响。
从 27 只角膜(15 位供体)中制备 DMEK 移植物(n=27),这些角膜符合移植条件,但由于与 COVID-19 相关的择期手术取消而无法分配。对 5 个原本计划进行移植的移植物进行细胞活力(通过 Calcein-AM 染色评估)和 ECD 评估,这些移植物是在原本计划的手术日进行评估的,而来自配对供体角膜的 22 个移植物则在直接准备后或储存 3-7 天后进行评估。通过光镜(LM ECD)和 Calcein-AM 染色(Calcein-ECD)分析 ECD。
所有移植物的光镜(LM)评估显示,移植物准备后内皮细胞单层无明显异常。然而,最初分配用于移植的 5 个移植物的 Calcein-ECD 中位数比 LM ECD 中位数低 18%(范围 9-73%)。对于配对的 DMEK 移植物,在移植物准备当天和移植物储存 3-7 天后通过 Calcein-AM 染色确定的 Calcein-ECD 分别显示中位数降低了 1%和 2%。准备后和储存 3-7 天后,中央移植物区域有活力细胞的中位数百分比分别为 88%和 92%。
大多数移植物的细胞活力不会受到准备和储存的影响。一些移植物在准备后数小时内可能会观察到内皮细胞损伤,但在 3-7 天的移植物储存期间,ECD 变化不大。在眼库中实施额外的准备后步骤,在移植物释放用于移植之前评估细胞密度,可能有助于减少术后 DMEK 并发症。